Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioMedix

BioMedix is a new biotechnology company that specializes in developing and manufacturing high quality, high performance, cutting-edge ELISA assays. At BioMedix, we are committed to providing the most comprehensive panel of high quality research and diagnostic reagents at the most reasonable prices. We offer products covering the areas of research in cytokines and chemokines, adhesion molecules, cancer research, and apoptosis.


Contact Details:
Kalymnou 5A Moschato
Athens
Attica
18345
Greece
Tel:+30 210 9581143
Fax:+30 210 9581168
Email:info@biomedix.gr
WWW:

www.biomedixlab.com




Recent Publications by BioMedix:

Ischemic damage and subsequent proliferation of oligodendrocytes in hippocampal CA1 region following repeated brief cerebral ischemia.
Changes in oligodendrocytes and astrocytes following repeated brief...
15th September, 2009
Kobuchisawa Research Laboratories, Fuji Biomedix Inc. Ltd., Japan. Pathobiology. 2009;76(4):204-11. Epub 2009 Jun 29.
DOI Direct Link
Cosmeceuticals and peptides.
In nature, the majority of chemical reactions, biological responses, and...
22nd August, 2009
Helix BioMedix Inc, Bothell, WA 98021, USA. Clin Dermatol. 2009 Sep-Oct;27(5):485-94.
DOI Direct Link
Xenopus laevis oocytes expressing human P-glycoprotein: Probing trans- and cis-inhibitory effects on [(3)H]vinblastine and [(3)H]digoxin efflux.
P-glycoprotein (P-gp; MDR1) recognizes and actively transports many...
28th July, 2009
Kobuchisawa Research Laboratories, Fuji Biomedix Co., Ltd., Hokuto-shi, Pharmacol Res. 2009 Jul 21.
DOI Direct Link
Bioactive peptides: signaling the future.
Natural processes within the body are modulated almost exclusively by the...
17th June, 2009
Helix Biomedix Inc, Bothell, WA, USA. J Cosmet Dermatol. 2009 Mar;8(1):8-13.
DOI Direct Link
Host defense peptides for use as potential therapeutics.
The ongoing emergence of bacterial strains resistant to multiple classes...
18th April, 2009
Helix BioMedix Curr Opin Investig Drugs. 2009 Feb;10(2):164-71.

View more BioMedix research publications.

Press Releases on BioMedix:

BioPortfolio Logo
African Americans at Significantly Higher Risk of DVT or Blood Clots 17th September, 2009 Venous Disease Coalition
Office of Minority Health Urges "Know Your Risk and Help Prevent Blood Clots" WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- Speaking at the Venous Disease Coalition (VDC) Annual Meeting
Celleration Appoints Mark T. Wagner President and Chief Executive Officer 1st July, 2009 Celleration, Inc.
EDEN PRAIRIE, Minn., July 1 /PRNewswire/ -- Celleration, Inc., developer of the patented MIST Therapy(R) System, an innovative device that uses ultrasound to heal wounds, has named Mark T. Wagner as
Top Doctors Urge Immediate Action to Prevent Deadly Blood Clots at Annual Meeting 9th September, 2008 The Venous Disease Coalition
WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- Members of the Venous Disease Coalition (VDC) and the Office of the Surgeon General will come together to urge immediate action to fight deadly blood
ev3 Inc. Reports Second Quarter 2008 Financial Results 28th July, 2008 ev3 Inc.
PLYMOUTH, Minn., July 28 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today reported financial results for its fiscal second quarter of 2008 and its

BioNews Results for BioMedix:

U.S. Patent Office approves multiple patent claims from Helix BioMedix
News-Medical.Net:  Nov 20 2009 7:33AM Matching: biomedix
Helix BioMedix Secures Additional Intellectual Property
Freshnews.com:  Nov 19 2009 8:50PM Matching: biomedix
Helix BioMedix Secures Additional Intellectual Property
Pharma Live:  Nov 19 2009 10:58PM Matching: biomedix
Helix BioMedix Secures Additional Intellectual Property
SmartBrief:  Nov 19 2009 6:31PM Matching: biomedix
Helix BioMedix, Inc. (HXBM) Secures Additional Intellectual Property
BioSpace:  Nov 19 2009 7:16PM Matching: biomedix
Promote your company here: BioNewsCast - Press Release Distribution

View more BioMedix news.

BioMedix Clinical Trials:

Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma

BioMedix Patents:

US Patent No.Title
7488216 Connector to receive blood test chips for use with a blood-substance measuring device
6255282 Lytic peptides
6034122 Combined use of diclofenac and tribenoside to treat osteoarthritis
6033866 Highly sensitive amperometric bi-mediator-based glucose biosensor
5962410 Inhibition of eucaryotic pathogens with lytic peptides

View more BioMedix patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 395 times since April 2007, the link to the organisation's website has been followed 73 times

Recent Search Terms used to find this page: biomedix greece | biomedix | biomedix | biomedix news | biomedix ELISA kits | biomedix | biomedix and ev3 | biomedix | BioMedix | .

Search for more companies in Athens

Search for more companies in Attica



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BioMedix

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.